CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF

Delisted

CNCR was delisted on the 27th of May, 2025.

22 hedge funds and large institutions have $16.1M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

2.96% less ownership

Funds ownership: 36.78%33.82% (-3%)

64% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 11

Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.9M
2
$724K
3
$655K
4
$607K
5
$559K
6
$489K
7
$442K
8
$418K
9
$290K
10
$248K
11
$204K
12
$192K
13
$119K
14
$60.8K
15
$50K
16
$37K
17
$32K
18
$31K
19
$26K
20
$21K
21
$16K
22
$4K
23
24
25